查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540795

2024-2032 年按产品、应用、程序、材料、用途、最终用户和地区分類的栓塞防护设备市场报告

Embolic Protection Devices Market Report by Product, Application, Procedure, Material, Usage, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球栓塞防护设备市场规模达到 11.575 亿美元。对微创手术的认识不断提高、心血管疾病盛行率不断上升以及医疗技术的众多进步是推动市场的一些主要因素。

栓塞防护装置是一种专门的医疗工具，旨在防止微创手术过程中碎片、血块或其他潜在有害颗粒的迁移，特别是在心血管干预过程中。这些设备可作为过滤器或屏障，捕获并容纳栓塞，否则栓塞可能会通过血流并导致中风或器官损伤等併发症。透过保护重要动脉并降低栓塞风险，这些设备提高了血管成形术、支架置入术和斑块旋切术等手术的安全性和成功率。因此，栓塞防护装置在整个医疗保健行业中得到了广泛的应用，因为它们透过最大限度地减少栓塞引起的术后併发症的可能性，在维护患者健康方面发挥着至关重要的作用。

由于动脉粥状硬化和冠状动脉疾病等心血管疾病的盛行率不断增加，对栓塞防护装置的需求不断增长，以减轻干预期间的栓塞风险，这将刺激预测期内栓塞防护装置市场的成长。此外，各医学专业也越来越多地采用微创技术，增加了对栓塞防护设备的需求。这些设备对于在血管成形术、支架置放术和经导管主动脉瓣置换术等复杂手术过程中保护病患安全至关重要。除此之外，众多技术进步，包括改进的过滤器设计和材料创新，提高了性能和患者治疗效果，正在推动市场成长。此外，对减少术后併发症和住院时间的高度重视加速了栓塞防护装置的采用，因为它有助于预防栓塞事件，从而促进市场成长。

栓塞保护装置市场趋势/驱动因素：

心血管疾病盛行率上升

动脉粥状硬化和冠状动脉疾病等心血管疾病的激增是栓塞防护设备市场的主要驱动力。随着全球人口老化和生活方式因素导致全球健康问题，血管成形术和支架置入术等干预措施变得越来越普遍。栓塞防护装置在降低栓塞风险方面发挥关键作用，栓塞是一种潜在的併发症，可能导致中风等严重后果。透过在这些手术过程中捕获和容纳碎片，这些设备显着提高了患者安全和整体手术结果。对栓塞防护装置的需求不断增长，源于医疗保健专业人员致力于解决全球心血管疾病日益沉重的负担并最大限度地减少相关手术风险。

越来越倾向微创手术

不同医学专业越来越多地采用微创技术刺激了对栓塞防护设备的需求。这些设备对于在经导管介入治疗等手术过程中确保患者安全至关重要，因为栓塞风险很大。随着患者和医疗保健提供者倾向于采用侵入性较小的方法，以提供更快的恢復和更短的住院时间，有效的栓塞防护的需求变得至关重要。这些设备对各种微创 (MI) 手术的适应性凸显了它们在现代医疗实践中的重要性，在优化患者治疗结果和手术成功方面发挥着至关重要的作用。

快速的技术进步

设备技术的持续创新，包括精緻的过滤器设计、先进的材料和改进的部署机制，是栓塞防护设备市场的关键驱动力。医疗保健专业人员寻求在干预期间提供增强性能和安全性的工具。栓塞防护装置的发展有效地满足了这些需求，提供更好的碎片捕获、简化的程序并改善患者的治疗效果。随着医疗领域越来越重视提高手术效率和患者福祉的新颖解决方案，对复杂的栓塞防护设备的需求推动了市场向前发展，为医生及其服务的患者提供了显着的好处。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球栓塞防护设备市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 远端过滤装置
    • 市场趋势
    • 市场预测
  • 远端闭塞装置
    • 市场趋势
    • 市场预测
  • 近端封堵器
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 冠状动脉治疗
    • 市场趋势
    • 市场预测
  • 颈动脉治疗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依程序

  • 经皮冠状动脉介入治疗
    • 市场趋势
    • 市场预测
  • 颈动脉狭窄
    • 市场趋势
    • 市场预测
  • 隐静脉移植干预
    • 市场趋势
    • 市场预测
  • 主动脉瓣狭窄（经导管主动脉瓣置换术）
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按材料

  • 镍钛合金
    • 市场趋势
    • 市场预测
  • 聚氨酯
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：依用途

  • 免洗设备
    • 市场趋势
    • 市场预测
  • 可重复使用的设备
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：依最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 门诊手术中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 12 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 13 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 14 章：价值链分析

第 15 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 16 章：价格指标

第17章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Allium Medical Solutions Ltd.
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Contego Medical LLC
    • Innovative Cardiovascular Solutions LLC
    • Edwards Lifesciences Corporation
    • Medtronic Inc.
    • Silk Road Medical Inc.
Product Code: SR112024A2202

The global embolic protection devices market size reached US$ 1,157.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,180.4 Million by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032. The increasing awareness of minimally invasive procedures, rising prevalence of cardiovascular diseases, and numerous advancements in medical technology are some of the major factors propelling the market.

Embolic protection devices are specialized medical tools designed to prevent the migration of debris, blood clots, or other potentially harmful particles during minimally invasive procedures, particularly in cardiovascular interventions. These devices act as filters or barriers, capturing and containing emboli that could otherwise travel through the bloodstream and cause complications such as stroke or organ damage. By safeguarding vital arteries and reducing the risk of embolization, these devices improve the safety and success rates of procedures like angioplasty, stent placement, and atherectomy. As a result, embolic protection devices find extensive applications across the healthcare industry as they play a crucial role in preserving patient well-being by minimizing the potential for post-procedural complications arising from embolism.

The rising demand for embolic protection devices to mitigate the risks of embolization during interventions due to the increasing prevalence of cardiovascular diseases such as atherosclerosis and coronary artery disease will stimulate the growth of the embolic protection devices market during the forecast period. Moreover, the increasing adoption of minimally invasive techniques across various medical specialties has augmented the demand for embolic protection devices. These devices are integral to preserving patient safety during complex procedures like angioplasty, stenting, and transcatheter aortic valve replacement. Apart from this, numerous technological advancements, including improved filter designs and material innovation, that enhance performance and patient outcomes, are propelling the market growth. Furthermore, the heightened emphasis on reducing post-procedural complications and hospital stays has accelerated the adoption of embolic protection devices as it assists in preventing embolic events, thereby contributing to the market growth.

Embolic Protection Devices Market Trends/Drivers:

Rise in prevalence of cardiovascular diseases

The surge in cardiovascular diseases like atherosclerosis and coronary artery diseases acts as a primary driver in the embolic protection device market. With an aging global population and lifestyle factors contributing to health concerns worldwide, interventions such as angioplasty and stent placement are becoming more prevalent. Embolic protection devices play a critical role in mitigating the risks of embolization, a potential complication that can lead to severe consequences like stroke. By capturing and containing debris during these procedures, these devices significantly improve patient safety and overall procedural outcomes. The growing demand for embolic protection devices stems from healthcare professionals' commitment to addressing the mounting burden of cardiovascular diseases globally and minimizing the associated procedural risks.

Growing inclination toward minimally invasive procedures

The increasing adoption of minimally invasive techniques across diverse medical specialties stimulates the demand for embolic protection devices. These devices are essential for ensuring patient safety during procedures like transcatheter interventions, where the risk of embolization is significant. As patients and healthcare providers gravitate toward less invasive approaches, offering quicker recovery and shorter hospital stays, the need for effective embolic protection becomes paramount. The adaptability of these devices to various minimally invasive (MI) procedures underscores their significance in modern medical practice, where they play a crucial role in optimizing patient outcomes and procedural success.

Rapid technological advancements

Continuous innovations in device technology, including refined filter designs, advanced materials, and improved deployment mechanisms, are pivotal drivers of the embolic protection device market. Healthcare professionals seek tools that deliver enhanced performance and safety during interventions. The evolution of embolic protection devices effectively addresses these demands, providing better debris capture, streamlined procedures, and improved patient outcomes. As the medical field increasingly prioritizes novel solutions that enhance both procedural efficacy and patient well-being, the quest for sophisticated embolic protection devices propel the market forward, offering significant benefits to medical practitioners and the patients they serve.

Embolic Protection Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global embolic protection devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application, procedure, material, usage and end-user.

Breakup by Product:

Distal Filter Devices

Distal Occlusion Devices

Proximal Occlusion Devices

Distal filter devices dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes distal filter, distal occlusion, and proximal occlusion devices. According to the report, distal filter devices represented the largest segment.

Distal filter devices have emerged as a driving force within the embolic protection devices market due to their pivotal role in minimizing embolic events during interventional procedures. These devices employ finely engineered filters positioned downstream to capture and contain debris released during procedures such as transcatheter interventions and angioplasty. By effectively intercepting emboli and preventing their migration to vital vessels, distal filter devices significantly mitigate the risk of complications, notably strokes.

Moreover, the growing recognition of their efficacy in preserving cerebral and peripheral circulation has spurred their adoption among healthcare professionals, leading to an increased demand for such devices. As a result, distal filter devices have enhanced patient outcomes and safety while supporting the overall growth trajectory of the embolic protection devices industry, underscoring their significance in modern medical interventions.

Breakup by Application:

Coronary Artery Treatment

Carotid Artery Treatment

Others

Coronary artery treatment holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes coronary artery treatment, carotid artery treatment, and others. According to the report, coronary artery treatment accounted for the largest market share.

Coronary artery treatment devices exert a substantial influence on the embolic protection devices market by addressing the inherent risk of embolic events in coronary interventions. These devices encompass a wide range of advanced technologies, including stents, angioplasty balloons, and atherectomy systems, all of which hold the potential to dislodge embolic debris during procedures. To counter this risk, embolic protection devices are integrated to capture and contain such debris, preventing its migration and minimizing adverse outcomes.

Furthermore, the growing demand for effective embolic protection strategies in coronary interventions has accelerated the adoption of dedicated embolic protection devices, as they strengthen the safety profile of coronary procedures, reducing the likelihood of complications such as myocardial infarctions and strokes. This symbiotic relationship between coronary artery treatment devices and embolic protection devices underscores their collective role in enhancing patient care and shaping the evolving landscape of cardiovascular interventions.

Breakup by Procedure:

Percutaneous Coronary Intervention

Carotid Artery Stenosis

Saphenous Vein Graft Intervention

Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)

Others

Percutaneous coronary intervention represents the most widely used procedure

The report has provided a detailed breakup and analysis of the market based on the procedure. This includes percutaneous coronary intervention, carotid artery stenosis, saphenous vein graft intervention, aortic valve stenosis (transcatheter aortic valve replacement), and others. According to the report, percutaneous coronary intervention represented the largest segment.

Percutaneous coronary intervention (PCI) significantly influences the embolic protection devices market due to its widespread use in treating coronary artery disease. PCI procedures involve the deployment of stents and other devices to open narrowed or blocked coronary arteries. However, these interventions carry the risk of embolic debris dislodgement, potentially leading to adverse events.

Furthermore, embolic protection devices play a crucial role in mitigating this risk by capturing and containing such debris, thereby reducing the chance of downstream embolization and associated complications. As PCI procedures continue to be a cornerstone of coronary artery disease management, the demand for effective embolic protection strategies has increased, fueling the growth of the market for embolic protection devices. This interdependence underscores the vital role of embolic protection devices in fortifying the safety and efficacy of percutaneous coronary interventions.

Breakup by Material:

Nitinol

Polyurethane

Nitinol represents the most popular material

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes nitinol and polyurethane. According to the report, nitinol accounted for the largest market share.

Nitinol, a shape memory alloy with remarkable flexibility and thermal properties, plays a crucial role in driving the embolic protection devices market. This material's unique attributes make it an ideal choice for constructing filters and frames in embolic protection devices. Nitinol's ability to undergo controlled deformation and return to its original shape when exposed to heat enables the creation of intricate yet resilient designs that can navigate tortuous vessels while maintaining structural integrity. This exceptional combination of properties enhances the performance of embolic protection devices by ensuring optimal vessel coverage and debris capture. As healthcare professionals seek devices that offer both efficacy and adaptability during interventions, Nitinol-based embolic protection devices stand out as an essential driver in shaping the market's growth, ultimately contributing to improved patient outcomes in various vascular procedures.

Breakup by Usage:

Disposable Devices

Re-Usable Devices

Disposable devices account for the majority of the market share

A detailed breakup and analysis of the market based on the usage has also been provided in the report. This includes disposable and re-usable devices. According to the report, disposable devices accounted for the largest market share.

Disposable devices aids in addressing critical concerns related to infection control, convenience, and cost-effectiveness. These disposable devices, designed for single-use applications, eliminate the need for reprocessing and sterilization, thereby minimizing the risk of cross-contamination and enhancing procedural efficiency. Moreover, they offer healthcare providers a hassle-free solution that reduces the burden of equipment maintenance.

Furthermore, the escalating demand for infection prevention measures and streamlined workflows has fueled the adoption of disposable embolic protection devices in various interventional procedures, spanning from endovascular interventions to transcatheter techniques. As medical settings prioritize patient safety and operational ease, the prominence of disposable embolic protection devices continues to escalate, substantiating their pivotal role in catalyzing the growth and evolution of the embolic protection devices market.

Breakup by End-User:

Hospitals and Clinics

Ambulatory Surgical Centers

Others

Hospitals and clinics represent the leading end user segment

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers, and others. According to the report, hospitals and clinics accounted for the largest market share.

As healthcare facilities, such as hospitals and clinics, continually strive to enhance patient outcomes and safety, the demand for effective embolic protection strategies has grown.

Moreover, hospitals and clinics actively seek advanced embolic protection devices to integrate into various interventional procedures, such as angioplasty, stent placement, and transcatheter interventions. The imperative to minimize the risk of embolic events, coupled with the need for streamlined procedural workflows, accelerates the adoption of these devices. Furthermore, as healthcare providers prioritize evidence-based practices, the utilization of embolic protection devices aligns with best practices for reducing complications and improving patient care, thus solidifying hospitals and clinics as key drivers in shaping the embolic protection devices market's expansion.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market due to its robust healthcare infrastructure, technological advancements, and high prevalence of cardiovascular diseases. The region's well-established healthcare facilities, coupled with a strong emphasis on patient safety and outcomes, catalyze the demand for effective embolic protection strategies. Favorable reimbursement policies and a propensity for adopting innovative medical technologies further stimulate the adoption of embolic protection devices in diverse cardiovascular interventions.

Additionally, the presence of various key players in the region and ongoing research initiatives contribute to the continuous evolution of embolic protection technologies. With its combination of clinical need, economic factors, and technological readiness, North America has emerged as a leading regional market for embolic protection devices.

Competitive Landscape:

Key players in the embolic protection devices market have recently introduced noteworthy innovations to address critical challenges. They have unveiled advanced embolic protection devices with improved navigational capabilities, real-time monitoring features, and enhanced thrombus capture efficiency. These innovations aim to provide healthcare professionals with greater precision and insight during complex procedures like transcatheter interventions and carotid artery stenting. Furthermore, the leading players have invested in developing integrated systems that seamlessly integrate with existing procedural workflows, streamlining the process and minimizing procedural time. These advancements reflect the industry's commitment to refining embolic protection strategies and reinforcing patient safety, thereby solidifying their role as frontrunners in shaping the landscape of embolic protection technologies. We also expect the market to witness new entrants, consolidation of product portfolios, and increased collaborations among manufacturers to drive healthy competition within the embolic protection devices domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Allium Medical Solutions Ltd.

Boston Scientific Corporation

Cardinal Health Inc.

Contego Medical LLC

Innovative Cardiovascular Solutions LLC

Edwards Lifesciences Corporation

Medtronic Inc.

Silk Road Medical Inc.

Recent Developments:

In January 2023, Cardinal Health Inc., a distinguished leader in healthcare services and medical products, embarked on a strategic collaboration with Palantir, a renowned technology company specializing in data integration and analysis. This innovative partnership marks a significant step forward in the realm of healthcare supply chain management. By joining forces, the companies aim to bring to fruition a cutting-edge clinically integrated supply chain solution that stands poised to revolutionize the way healthcare organizations manage their inventory and distribution processes.

In April 2021, Contego Medical LLC, a prominent pioneer in the realm of cardiovascular devices, achieved a significant milestone by securing the highly coveted CE Mark approval for its cutting-edge innovation, the Neuroguard IEP(R) 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System). This announcement marks a noteworthy advancement in the field of interventional cardiology. The Neuroguard IEP System's multifaceted approach encapsulates both a carotid stent and a post-dilation balloon, synergistically integrated with state-of-the-art embolic protection mechanisms.

In March 2021, Innovative Cardiovascular Solutions (ICS) LLC, a dynamic global player in the medical device industry, unveiled a significant stride in its pursuit of providing a holistic and pioneering approach to embolic protection within structural heart and vascular interventions. With a strong focus on advancing patient care, the company has announced the successful execution of its initial European clinical cases, showcasing the latest iteration of their revolutionary EMBLOK(TM) Embolic Protection System.

Key Questions Answered in This Report

  • 1. What was the size of the global embolic protection devices market in 2023?
  • 2. What is the expected growth rate of the global embolic protection devices market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global embolic protection devices market?
  • 4. What are the key factors driving the global embolic protection devices market?
  • 5. What is the breakup of the global embolic protection devices market based on the product?
  • 6. What is the breakup of the global embolic protection devices market based on the application?
  • 7. What is the breakup of the global embolic protection devices market based on the procedure?
  • 8. What is the breakup of the global embolic protection devices market based on the material?
  • 9. What is the breakup of the global embolic protection devices market based on the usage?
  • 10. What is the breakup of the global embolic protection devices market based on the end-user?
  • 11. What are the key regions in the global embolic protection devices market?
  • 12. Who are the key players/companies in the global embolic protection devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Embolic Protection Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Distal Filter Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Distal Occlusion Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Proximal Occlusion Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Coronary Artery Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Carotid Artery Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Percutaneous Coronary Intervention
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Carotid Artery Stenosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Saphenous Vein Graft Intervention
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Material

  • 9.1 Nitinol
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Polyurethane
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Usage

  • 10.1 Disposable Devices
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Re-Usable Devices
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals and Clinics
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Indicators

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 Allium Medical Solutions Ltd.
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 Financials
    • 17.3.3 Boston Scientific Corporation
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
      • 17.3.3.3 Financials
      • 17.3.3.4 SWOT Analysis
    • 17.3.4 Cardinal Health Inc.
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 Financials
      • 17.3.4.4 SWOT Analysis
    • 17.3.5 Contego Medical LLC
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
    • 17.3.6 Innovative Cardiovascular Solutions LLC
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
    • 17.3.7 Edwards Lifesciences Corporation
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 Financials
      • 17.3.7.4 SWOT Analysis
    • 17.3.8 Medtronic Inc.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
      • 17.3.8.4 SWOT Analysis
    • 17.3.9 Silk Road Medical Inc.
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials

List of Figures

  • Figure 1: Global: Embolic Protection Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Embolic Protection Devices Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Embolic Protection Devices Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Embolic Protection Devices Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Embolic Protection Devices Market: Breakup by Procedure (in %), 2023
  • Figure 6: Global: Embolic Protection Devices Market: Breakup by Material (in %), 2023
  • Figure 7: Global: Embolic Protection Devices Market: Breakup by Usage (in %), 2023
  • Figure 8: Global: Embolic Protection Devices Market: Breakup by End-User (in %), 2023
  • Figure 9: Global: Embolic Protection Devices Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Embolic Protection Devices (Distal Filter Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Embolic Protection Devices (Distal Filter Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Embolic Protection Devices (Distal Occlusion Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Embolic Protection Devices (Distal Occlusion Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Embolic Protection Devices (Proximal Occlusion Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Embolic Protection Devices (Coronary Artery Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Embolic Protection Devices (Coronary Artery Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Embolic Protection Devices (Carotid Artery Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Embolic Protection Devices (Carotid Artery Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Embolic Protection Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Embolic Protection Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Embolic Protection Devices (Percutaneous Coronary Intervention) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Embolic Protection Devices (Carotid Artery Stenosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Embolic Protection Devices (Saphenous Vein Graft Intervention) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Embolic Protection Devices (Aortic Valve Stenosis- Transcatheter Aortic Valve Replacement) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Embolic Protection Devices (Other Procedures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Embolic Protection Devices (Other Procedures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Embolic Protection Devices (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Embolic Protection Devices (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Embolic Protection Devices (Polyurethane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Embolic Protection Devices (Polyurethane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Embolic Protection Devices (Disposable Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Embolic Protection Devices (Disposable Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Embolic Protection Devices (Re-Usable Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Embolic Protection Devices (Re-Usable Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Embolic Protection Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Embolic Protection Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Embolic Protection Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Embolic Protection Devices (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Embolic Protection Devices (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: North America: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: North America: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United States: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United States: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Canada: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Canada: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Asia Pacific: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Asia Pacific: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: China: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: China: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Japan: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Japan: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: India: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: India: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: South Korea: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: South Korea: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Australia: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Australia: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Indonesia: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Indonesia: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Europe: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Europe: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Germany: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Germany: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: France: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: France: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: United Kingdom: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: United Kingdom: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Italy: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Italy: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Spain: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Spain: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Russia: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Russia: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Latin America: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Latin America: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Brazil: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Brazil: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Mexico: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Mexico: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Others: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Others: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Middle East and Africa: Embolic Protection Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Middle East and Africa: Embolic Protection Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Global: Embolic Protection Devices Industry: SWOT Analysis
  • Figure 96: Global: Embolic Protection Devices Industry: Value Chain Analysis
  • Figure 97: Global: Embolic Protection Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Embolic Protection Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Embolic Protection Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Embolic Protection Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Embolic Protection Devices Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 5: Global: Embolic Protection Devices Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 6: Global: Embolic Protection Devices Market Forecast: Breakup by Usage (in Million US$), 2024-2032
  • Table 7: Global: Embolic Protection Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 8: Global: Embolic Protection Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Embolic Protection Devices Market: Competitive Structure
  • Table 10: Global: Embolic Protection Devices Market: Key Players